EUCTR2007-000214-37-NL进行中(未招募)不适用
Biological and biochemical markers of aneurysm wall degradation; towards non-invasive wall strength analysis. - Biomarkers for aneurysm wall strength
MC St Radboud0 个研究点开始时间: 2007年4月17日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •· Forty patients scheduled for conventional repair of an asymptomatic or
- •symptomatic (non-ruptured) aneurysm.
- •· Informed consent
- •· Clinical condition allows MR imaging (USPIO group)
- •· Preoperative CT (computer tomography)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •· Ruptured aneurysm
- •· Patient characteristics and aneurysm anatomy suitable for endovascular repair
- •· Contraindication for MR imaging like metallic implants or claustrophobia
- •(USPIO group).
- •· Previous aortic aneurysm surgery
- •· Severe cardiac co-morbidity (e.g. Chronic Heart Failure, Caronary artery disease).
研究者
相似试验
尚未招募
不适用
Biological and biochemical markers of aneurysm wall degradation; towards non-invasive wall strength analysis.Abdominal Aortic dilatationarterial bulge1000318410002363NL-OMON30536niversitair Medisch Centrum Sint Radboud40
Unknown
不适用
Biomarkers of Aneurysm Wall StrengthAbdominal Aortic AneurysmNCT00740740Radboud University Medical Center50
已完成
不适用
Intracranial aneurysms: searching for markers of instability and risk of ruptureNL-OMON38220niversitair Medisch Centrum Utrecht210
招募中
不适用
The study of biomarkers for intractable vascular anomalies and associated with pharmacological action of sirolimusVascular anomaliesJPRN-UMIN000029173Gifu University50
已完成
不适用
Admission Bio-clinical Score to Predict One-year Outcomes in Coiled Subarachnoid Hemorrhage (SAH)Aneurysmal Subarachnoid HemorrhageNCT01357057Assistance Publique - Hôpitaux de Paris530
